Completed NA INTERVENTIONAL 1-arm
NCT07102537
Evaluation of Efficacy and Safety of Intella Dermal Filler in Moderate to Severe Nasolabial Folds
A Single-Arm, Before- After Clinical Study to Evaluate the Safety and Efficacy of Intella Dermal Filler (Produced by Espad Pharmed Darou Co.) for Correction of Moderate to Severe Nasolabial Folds
Sponsor: Espad Pharmed
Conditions
Nasolabial Fold Correction
Updated 1 time since 2025 Last updated: Jul 28, 2025 Started: Jan 2, 2024 Primary completion: Feb 14, 2024 Completion: Feb 28, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A NA clinical study on Nasolabial Fold Correction, this trial is completed. The trial is conducted by Espad Pharmed and has accumulated 1 data snapshot since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Completed — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Espad Pharmed
Data source: Espad Pharmed
For direct contact, visit the study record on ClinicalTrials.gov .